The therapeutic potential of anti-cytokine antibodies in the treatment of chronic inflammatory disease

By Davidson N.J.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 7, 1998-07 ,pp. : 1115-1120

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Targets in Inflammatory Disease

By  

Current Medicinal Chemistry, Vol. 12, Iss. 25, 2005-12 ,pp. : 2925-2929

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory Mechanisms and Oxidative Stress in Peyronie's Disease: Therapeutic “Rationale” and Related Emerging Treatment Strategies

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 1, 2012-02 ,pp. : 48-57

Bentham Science Publishers

Access to resources Recommend Favorite

Designing and Testing New Therapeutic Modalities for Treatment of Inflammatory Bowel Disease: Role of Experimental Animal Models

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 3, 2005-06 ,pp. : 297-317

Bentham Science Publishers

Access to resources Recommend Favorite

Mesalazine for the treatment of inflammatory bowel disease

By Criscuoli Valeria  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1669-1678

Informa Healthcare

Access to resources Recommend Favorite